Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatobiliary transport.

G A Kullak-Ublick1, U Beuers, G Paumgartner

  • 1Department of Medicine, University Hospital, Zurich, Switzerland.

Journal of Hepatology
|March 23, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics of ceftriaxone, gentamicin, meropenem and vancomycin in liver cirrhosis: a systematic review.

The Journal of antimicrobial chemotherapy·2024
Same author

Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet.

Pharmacological research·2023
Same author

Doppler follow-up after TIPS placement is not routinely indicated. A 16-years single centre experience.

The Netherlands journal of medicine·2020
Same author

[Immune-mediated cholangiopathies : Diagnostic and therapeutic challenges].

Der Radiologe·2019
Same author

[IgG4-associated cholangitis - clinical presentation of an overlooked disease entity].

Der Internist·2018
Same author

[Chronic cholestatic liver diseases : Differential diagnosis, pathogenesis and current treatment in adults].

Der Internist·2017
Same journal

Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study.

Journal of hepatology·2026
Same journal

Reply to "Role of HBV genotype, monitoring, and events after cessation of nucleos(t)ide analogue therapy".

Journal of hepatology·2026
Same journal

When Biology Pushes Back: Lessons From HBsAg-Targeting Therapies in Hepatitis Delta.

Journal of hepatology·2026
Same journal

Moving Too Fast? A Meta-Analysis Calls for Caution on TNF Inhibitors as First-Line Therapy for Autoimmune Hepatitis.

Journal of hepatology·2026
Same journal

Anserine restores antibacterial immunity in cirrhosis via a protective CCL5-mediated hepatocyte-CD44<sup>+</sup>pDC crosstalk.

Journal of hepatology·2026
Same journal

Anti-CCL2-conjugated platelets attenuate early allograft and ischemia-reperfusion injury by inhibiting monocyte infiltration.

Journal of hepatology·2026
See all related articles

Cholestasis disrupts bile salt transport in liver cells, altering transporter expression and function. Bile acids regulate this process via the farnesoid X receptor, impacting bile acid circulation.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Biochemistry

Background:

  • Cholestasis involves impaired hepatobiliary transport, stemming from primary genetic defects or secondary biliary obstruction.
  • These defects lead to hepatocellular accumulation of toxic compounds and altered transporter expression.

Purpose of the Study:

  • To elucidate the mechanisms of altered hepatobiliary transport in cholestasis.
  • To understand the role of bile acids and their receptors in regulating transporter function.

Main Methods:

  • Analysis of transporter gene expression and function in cholestatic models.
  • Investigation of bile acid-mediated regulation of hepatocellular transporters.

Main Results:

  • Cholestasis causes primary defects (gene mutations) and secondary defects (biliary obstruction) in bile secretion.

Related Experiment Videos

  • Hepatocellular transporters like NTCP, BSEP, and MRP2 show altered expression, with inverse regulation of apical and basolateral systems.
  • Bile acids act as ligands for the farnesoid X receptor, regulating genes involved in bile acid transport and metabolism.

    • Conclusions:

    • Hepatobiliary transport defects in cholestasis are complex, involving altered transporter expression and function.
    • Bile acid-mediated signaling via the farnesoid X receptor is crucial for maintaining bile acid homeostasis.